These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30565246)
1. Zero tolerance! A perspective on monogenic disorders with defective regulatory T cells and IBD-like disease. Abdel-Motal UM; Al-Shaibi A; Elawad M; Lo B Immunol Rev; 2019 Jan; 287(1):236-240. PubMed ID: 30565246 [TBL] [Abstract][Full Text] [Related]
2. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Uhlig HH Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review. Ding X; Bin P; Wu W; Chang Y; Zhu G Mediators Inflamm; 2020; 2020():9706140. PubMed ID: 32617076 [TBL] [Abstract][Full Text] [Related]
4. Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. Gibson DJ; Ryan EJ; Doherty GA Inflamm Bowel Dis; 2013 Nov; 19(12):2716-24. PubMed ID: 23899545 [TBL] [Abstract][Full Text] [Related]
7. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance. Shen X; Du J; Guan W; Zhao Y Expert Rev Clin Immunol; 2014 Mar; 10(3):353-62. PubMed ID: 24483245 [TBL] [Abstract][Full Text] [Related]
8. Novel molecular defects associated with very early-onset inflammatory bowel. Ciullini Mannurita S; Gambineri E Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):317-324. PubMed ID: 28817385 [TBL] [Abstract][Full Text] [Related]
9. Disrupted regulatory T cell homeostasis in inflammatory bowel diseases. Pedros C; Duguet F; Saoudi A; Chabod M World J Gastroenterol; 2016 Jan; 22(3):974-95. PubMed ID: 26811641 [TBL] [Abstract][Full Text] [Related]
10. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases. Fiyouzi T; Pelaez-Prestel HF; Reyes-Manzanas R; Lafuente EM; Reche PA Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175505 [TBL] [Abstract][Full Text] [Related]
11. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production. Yu L; Yang F; Zhang F; Guo D; Li L; Wang X; Liang T; Wang J; Cai Z; Jin H Cell Death Dis; 2018 Sep; 9(9):905. PubMed ID: 30185773 [TBL] [Abstract][Full Text] [Related]
12. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease. Lord JD; Shows DM; Chen J; Thirlby RC PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224 [TBL] [Abstract][Full Text] [Related]
13. Environmental influences on T regulatory cells in inflammatory bowel disease. Hardenberg G; Steiner TS; Levings MK Semin Immunol; 2011 Apr; 23(2):130-8. PubMed ID: 21295492 [TBL] [Abstract][Full Text] [Related]
14. Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T Cells. Rieder SA; Metidji A; Glass DD; Thornton AM; Ikeda T; Morgan BA; Shevach EM J Immunol; 2015 Jul; 195(2):553-63. PubMed ID: 26062998 [TBL] [Abstract][Full Text] [Related]
15. Intestinal Regulatory T Cells. Figliuolo da Paz VR; Jamwal DR; Kiela PR Adv Exp Med Biol; 2021; 1278():141-190. PubMed ID: 33523448 [TBL] [Abstract][Full Text] [Related]